American Heart Journal
| 短名 | Am. Heart J. |
| Journal Impact | 3.79 |
| 国际分区 | CARDIAC & CARDIOVASCULAR SYSTEMS(Q1) |
| 期刊索引 | SCI Q2中科院 2 区 |
| ISSN | 0002-8703, 1097-6744 |
| h-index | 206 |
| 国内分区 | 医学(2区)医学心脏和心血管系统(3区) |
The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.
期刊主页投稿网址| 涉及主题 | 医学内科学心脏病学生物外科心理学放射科精神科内分泌学病理麻醉心肌梗塞 |
| 出版信息 | 出版商: Elsevier Inc.，出版周期: Monthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1925，原创研究文献占比: 93.82%，自引率:2.70%， Gold OA占比: 28.70% |
| 平均审稿周期 | 网友分享经验：一般,3-6周来源Elsevier官网：平均7.1周 |
| 平均录用比例 | 网友分享经验：较难 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Blood and urine metal levels in patients with diabetes and cardiovascular disease
2024-11-1
Response to Tomoyuki Kawada: Blood and urine metal levels in patients with diabetes and cardiovascular disease
2024-11-1
Predicted prosthesis–patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study
2024-10-1
Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial
2024-10-1
Current practices in the management of temporary mechanical circulatory support: A survey of CICU directors in North America
2024-10-1
Sarcopenia and frailty in patients undergoing transcatheter aortic valve replacement
2024-10-1
Malignant Left Ventricular Hypertrophy and Risk of Cognitive Impairment in SPRINT MIND Trial
2024-10-1
Information for Readers
2024-9-4
Editorial Board
2024-9-4
Table of Contents
2024-9-4
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: rationale and design of the COL BE PCI trial
2024-9-1
Intramuscular versus Enteral Penicillin Prophylaxis to Prevent Progression of Rheumatic Heart Disease: Study protocol for a non-inferiority randomized trial (the GOALIE trial)
2024-9-1
Overview of 2024 FDA Advisory Panel Meeting on the TriClip Transcatheter Tricuspid Valve Repair System
2024-9-1
Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: rationale and design of the IRONMAN-II trial
2024-9-1
Association of Disproportionate Liver Fat with Markers of Heart Failure: The Multi-Ethnic Study of Atherosclerosis
2024-9-1
Seattle Proportional Risk Model in GISSI-HF: Estimated Benefit of ICD in Patients with EF less than 50%
2024-9-1
The relative merits of using a high-sensitivity cardiac Troponin T assay compared to a non-high-sensitivity Troponin T assay after noncardiac surgery
2024-9-1
Design and Rationale of the Social Determinants of the Risk of Hypertension in Women of Reproductive Age (SAFE HEART) Study: An American Heart Association Research Goes Red Initiative
2024-9-1
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials
2024-9-1
Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) Study
2024-9-1
Arrhythmias in Congenital Heart Disease: a Nationwide Cohort Study
2024-9-1
Editorial Board
2024-9-1
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: rationale and design of the CRAFT trial
2024-9-1
Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction
2024-9-1
Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction
2024-9-1
REGENERATE-COBRA: A Phase II randomized sham-controlled trial assessing the safety and efficacy of intracoronary administration of autologous bone marrow-derived cells in patients with refractory angina
2024-9-1
Information for Readers
2024-9-1
Table of Contents
2024-9-1
Renin angiotensin system inhibitors and outcome in patients with Takotsubo syndrome: a propensity score analysis of the GEIST registry
2024-9-1
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report
2024-9-1
Design and Rationale of the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction
2024-9-1
Risk of Cardiovascular Events after Influenza Infection-related Hospitalizations in Adults with Congenital Heart Disease -A Nationwide Population Based Study
2024-9-1
A Bridge to Comfort: Palliative Inotrope Infusion for Patients with Heart Failure in Hospice Care
2024-9-1
Table of Contents
2024-8-24
Information for Readers
2024-8-24
Editorial Board
2024-8-24
Use of artificial intelligence‐guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE‐echo trial
2024-8-10
Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: A SWEDEHEART study
2024-8-10
Impact of sex on outcomes associated with polyvascular disease in patients after PCI
2024-8-8
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
2024-8-3
A Randomized Comparison of the Treatment Sequence of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Implantation: Rationale and Design of the TAVI PCI Trial
2024-8-1
Heart Failure and nocturnal hypoxemic burden, the connection is getting closer and closer
2024-8-1
Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the United States: A Cohort Study
2024-8-1
The Pathophysiology of Patent Foramen Ovale and Its Related Complications
2024-8-1
Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension
2024-8-1
Accelerometer-Measured Physical Activity in Patients with Heart Failure and Reduced Ejection Fraction: Determinants and Relationship with Patient-Reported Health Status
2024-8-1
BASELINE Trial: Update in study design
2024-8-1
Safety and feasibility of triage and rapid discharge of patients with chest pain from emergency room: a pragmatic, randomised non-inferiority control trial of the European Society of Cardiology (ESC) 0–1 hour pathway vs. conventional 0-3 hour accelerated diagnostic protocol.
2024-8-1
Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry
2024-8-1
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
2024-8-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远